Use the journals feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
JOURNAL ARTICLE
Kevin E Chan, Elazer R Edelman, Julia B Wenger, Ravi I Thadhani, Franklin W Maddux
BACKGROUND: Dabigatran and rivaroxaban are new oral anticoagulants that are eliminated through the kidneys. Their use in dialysis patients is discouraged because these drugs can bioaccumulate to precipitate inadvertent bleeding. We wanted to determine whether prescription of dabigatran or rivaroxaban was occurring in the dialysis population and whether these practices were safe. METHODS AND RESULTS: Prevalence plots were used to describe the point prevalence (monthly) of dabigatran and rivaroxaban use among 29977 hemodialysis patients with atrial fibrillation...
March 17, 2015: Circulation
#2
JOURNAL ARTICLE
Ezra A Amsterdam, Nanette K Wenger, Ralph G Brindis, Donald E Casey, Theodore G Ganiats, David R Holmes, Allan S Jaffe, Hani Jneid, Rosemary F Kelly, Michael C Kontos, Glenn N Levine, Philip R Liebson, Debabrata Mukherjee, Eric D Peterson, Marc S Sabatine, Richard W Smalling, Susan J Zieman
No abstract text is available yet for this article.
December 23, 2014: Circulation
#3
REVIEW
Ming Ding, Shilpa N Bhupathiraju, Ambika Satija, Rob M van Dam, Frank B Hu
BACKGROUND: Considerable controversy exists on the association between coffee consumption and cardiovascular disease (CVD) risk. A meta-analysis was performed to assess the dose-response relationship of long-term coffee consumption with CVD risk. METHODS AND RESULTS: PubMed and EMBASE were searched for prospective cohort studies of the relationship between coffee consumption and CVD risk, which included coronary heart disease, stroke, heart failure, and CVD mortality...
February 11, 2014: Circulation
#4
JOURNAL ARTICLE
Karen M Olsson, Marion Delcroix, H Ardeschir Ghofrani, Henning Tiede, Doerte Huscher, Rudolf Speich, Ekkehard Grünig, Gerd Staehler, Stephan Rosenkranz, Michael Halank, Matthias Held, Tobias J Lange, Juergen Behr, Hans Klose, Martin Claussen, Ralf Ewert, Christian F Opitz, C Dario Vizza, Laura Scelsi, Anton Vonk-Noordegraaf, Harald Kaemmerer, J Simon R Gibbs, Gerry Coghlan, Joanna Pepke-Zaba, Uwe Schulz, Matthias Gorenflo, David Pittrow, Marius M Hoeper
BACKGROUND: For almost 30 years, anticoagulation has been recommended for patients with idiopathic pulmonary arterial hypertension (IPAH). Supporting evidence, however, is limited, and it is unclear whether this recommendation is still justified in the modern management era and whether it should be extended to patients with other forms of pulmonary arterial hypertension (PAH). METHODS AND RESULTS: We analyzed data from Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA), an ongoing European pulmonary hypertension registry...
January 7, 2014: Circulation
#5
REVIEW
Wolfgang Lieb, Ramachandran S Vasan
No abstract text is available yet for this article.
September 3, 2013: Circulation
#6
Patricia E Longmuir, Julie A Brothers, Sarah D de Ferranti, Laura L Hayman, George F Van Hare, G Paul Matherne, Christopher K Davis, Elizabeth A Joy, Brian W McCrindle
No abstract text is available yet for this article.
May 28, 2013: Circulation
1
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
